Market Overview

Benzinga's M&A Chatter for Thursday August 6, 2015

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday August 4, 2015:

IBM to Acquire Merge Healthcare for $7.13/Share in Cash

The Deal:
IBM (NYSE: IBM) announced Thursday, that it plans to acquire Merge Healthcare (NASDAQ: MRGE) for 7.13 per share in cash, for a total transaction value of $1 billion. The deal is expected to close later this year.

Merge closed at $7.10 on Thursday, a gain of 31%.

Mesa Labs Acquires Dental Sterilizer Testing Business for $11.25M

The Deal:
Mesa Laboratories, Inc. (NASDAQ: MLAB) announced Thursday, the acquisition of substantially all of the assets and certain liabilities of the dental sterilizer testing business of North Bay Bioscience, LLC. for $11,250,000 in cash.

Mesa Labs closed at $119.57 Thursday, a gain of 1%.

Coca-Cola Enterprises Merges With Coca-Cola Iberian Partners, Coca-Cola Erfrischungsgetränke AG

The Deal:
Coca-Cola Enterprises, Inc. (NYSE: CCE), Coca-Cola Iberian Partners SA and Coca-Cola Erfrischungsgetränke AG , a wholly owned subsidiary of The Coca-Cola Company (NYSE: KO), announced Thursday, that they have agreed to combine their businesses into a new company to be called Coca-Cola European Partners Plc. The new company will become the world's largest independent Coca-Cola bottler based on net revenues.

Coca-Cola Enterprises closed at $53.39 Thursday, a gain of almost 3%.

Posted-In: M&A News Rumors Movers

 

Related Articles (CCE + IBM)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Brusuelas: Use The Russell 2000 To Track The Economy, Not Large-Caps

It's Impossible To Sell Your Home In These 25 Cities